CIPLA - Swing Trade Analysis with AI Signals

Last Updated Time : 19 Sept 25, 2:15 pm

Swing Trade Rating: 4.3

📊 Technical & Momentum Overview

✅ Strengths

Price Action: Trading above both 50 DMA (₹1,544) and 200 DMA (₹1,508), confirming short-term and medium-term strength.

MACD (6.05): Positive and rising, indicating bullish momentum.

RSI (56.4): Neutral-bullish zone, with room to rise before overbought.

Volume: Above 1-week average—momentum supported by participation.

52W Index (68.4%): Strong relative performance, trending toward yearly high.

📈 Fundamental Snapshot

ROCE (20.1%) & ROE (16.0%): Solid capital efficiency.

EPS (₹66.9) vs P/E (24.7): Reasonable valuation for pharma sector.

PEG (1.35): Fair growth-adjusted pricing.

Zero Debt: Clean balance sheet adds margin of safety.

Qtr Profit Growth (+23.4%): Strong earnings momentum.

DII Inflow (+1.09%): Domestic institutional support.

⚠️ Watchouts

FII Outflow (-1.04%): Mild foreign investor caution.

Dividend Yield (0.82%): Low income support—pure growth play.

🎯 Optimal Entry Price

Buy Zone: ₹1,540–₹1,555 (near 50 DMA and VWAP)

Momentum Entry: ₹1,585–₹1,595 if RSI crosses 58 and MACD strengthens

🚪 Exit Strategy (If Already Holding)

Target Exit: ₹1,675–₹1,690 (near 52W high and resistance zone)

Stop Loss: ₹1,505 (below 200 DMA and recent support)

Exit Trigger: RSI > 70 or MACD flattens

Selva, CIPLA offers a well-balanced swing setup with strong technicals and solid fundamentals. If you're building a healthcare basket or want alert logic for RSI/MACD thresholds, I can help you script it.

Edit in a page